NCT01528501View on ClinicalTrials.gov

Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)

PHASE2TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

February 28, 2013

Conditions
Metastatic Gastric Cancer
Interventions
DRUG

Panobinostat (LBH589)

Trial Locations (2)

68167

Universitätsklinikum Mannheim, Mannheim

81675

Klinikum rechts der Isar, Munich

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Technical University of Munich

OTHER